HIV and cancer of the cervic

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 19, Issue 2 SPEC. ISS., 2005, Pages 269-276

  Chirenje, Z M ^a  

^a UNIVERSITY OF ZIMBABWE   (Zimbabwe)

Author keywords

Cervical cytology; Cervical intraepithelial neoplasia (CIN); Human immunodeficiency virus (HIV); Human papillomavirus (HPV); Invasive cervical cancer (ICC)

Indexed keywords

ANTIRETROVIRUS AGENT; CISPLATIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

AFRICA; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CANCER RISK; CAUSE OF DEATH; COLPOSCOPY; DISEASE ASSOCIATION; DISEASE COURSE; EPIDEMIC; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYSTERECTOMY; IMMUNOSURVEILLANCE; LABORATORY DIAGNOSIS; MORTALITY; MULTIMODALITY CANCER THERAPY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RISK FACTOR; SOCIAL BEHAVIOR; SYMPTOMATOLOGY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; ADULT; AFRICA SOUTH OF THE SAHARA; DEVELOPING COUNTRY; HUMAN IMMUNODEFICIENCY VIRUS 1; MIDDLE AGED; REVIEW; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY; VIRUS INFECTION;

ADULT; AFRICA SOUTH OF THE SAHARA; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CERVICAL INTRAEPITHELIAL NEOPLASIA; DEVELOPING COUNTRIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 15044349608     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2004.10.002     Document Type: Review

References (47)

1. D.M. Parkin F.I. Bray S.S. Devesa Cancer burden in the year 2000. The global picture Eur J Cancer 37 supplement 8 2001 554-566
2. Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organisation. AIDS Epidemic Update: December 2003.
3. Centers for Disease Control and Prevention 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults Morb Mort Wkly Rep 41 1993 1-19
4. M. Maiman R.G. Frutcher L. Guy et al. Human immunodeficiency virus infection and invasive cancer Cancer 71 1993 402-506
5. M. Maiman R.G. Frutchter M. Clark Cervical et al. cancer as an AIDS-defining illness Obstet & Gynaecol 89 1 1997 76-80
6. J.M. Palefsky H. Minkoff L.A. Kalish et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus (HIV)-1 positive and high risk HIV-negative women J Natl Cancer Inst 91 1999 226-236
7. M. Conti A. Agarossi F. Parazzini HPV et al. infection and risk of cervical intraepithelial neoplasia in former intravenous drug abusers Gynaecol Oncol 49 1993 344-348
8. T.V. Ellerbrock M.A. Chiasson T.J. Bush et al. Incidence of cervical squamous intraepithelial neoplasia in HIV infected women JAMA 283 2000 1031-1037
9. S.E. Hawes C.W. Critchlow M.A. Faye Niang et al. Increased risk of high-grade cervical squamous intraepithelial lesions and cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections J Infect Dis 188 2003 555-563
10. P. Schuman S.E. Ohmit R.S. Klein et al. HIV Epidemiology Research Study (HERS). Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV) seropositive and at risk HIV-seronegative women J Infect Dis 188 1 2003 128-136
11. B. Clark R. Chetty Postmodern cancer: The role of human immunodeficiency virus in uterine cervical cancer Mol Biol 55 1 2002 19-24
12. M.A. Relliham D.O. Dooley T.W. Burke et al. Rapidly progressive cervical cancer in a patient with human immunodeficiency virus infection Gynaecol Oncol 36 1990 435-438
13. P. Saccucci M. Mastrone P. Are et al. Rapidly progressive squamous cell carcinoma of the cervix in a patient with acquired immunodeficiency syndrome: Case report Eur J Gynaecol Oncol 17 4 1996 306-308
14. K. Holcomb M. Maiman T. Dimaio J. Gates Rapid progress to invasive cervical cancer in a woman infected with human immunodeficiency virus Obstet Gynaecol 91 1998 848-850
15. K.M. Chin J.S. Sidhu R.S. Janssen J.T. Weber Invasive cervical cancer in human immunodeficiency virus-infected and uninfected hospital patients Obstet Gynaecol 92 1 1998 83-87
16. L.S. Massad E.C. Seaberg D.H. Watts et al. Low incidence of invasive cervical cancer among HIV-infected US women in a prevention program AIDS 18 2004 109-113
17. R. Newton J. Ziegler V. Beral et al. A case-control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda Int J Cancer 91 2001 622-627
18. F. Sitas R. Pacella-Norman H. Carrara et al. The spectrum of HIV-1 related cancers in South Africa Int J Cancer 88 2000 489-492
19. P.B. Gichangi J. Bwayo et al. Estambale Impact of HIV infection on invasive cervical cancer in Kenya AIDS 17 13 2003 1963-1968
20. E. Chokunonga L. Levy M. Bassett et al. AIDS and cancer in Africa. The evolving epidemic in Zimbabwe AIDS 13 1999 2583-2588
21. H.J. Bontkes J.M.M. Walboomers C.J.L.M. Meijer et al. Specific HLA class 1 down-regulation is an early event in cervical dysplasia associated with clinical progression Lancet 351 1998 187-188
22. S.A. Southern C.S. Herrington Disruption of cell cycle control by human papillomavirus with special reference to cervical carcinoma Int J Gynaecol Cancer 10 2000 263-274
23. M.C. Delmas C. Larsen B. Van Benthem et al. Cervical squamous intraepithelial lesions in HIV infected women: Prevalence, incidence and regression. European study group on natural history of HIV infection in women AIDS 14 2000 1775-1784
24. I. Heard J.M. Tassie V. Schmitz et al. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load Obstet Gynaecol 96 2000 403-409
25. M. Laga J.P. Icenogle R. Marsella et al. Genital papillomavirus infection and cervical dysplasia - Opportunistic complications of HIV infection Int J Cancer 50 1992 45-48
26. M. Maiman R.G. Fruchter A. Sedlis et al. Prevalence, risk factors and accuracy of cytological screening for cervical intraepithelial neoplasia in women with human immunodeficiency virus Gynaecol Oncol 68 1998 233-239
27. S.D. Womack Z.M. Chirenje L. Gaffikin et al. HPV based cervical cancer screening in a population at high risk for HIV infection Int J Cancer 85 2000 206-210
28. T.C. Wright T.V. Ellerbrock M.A. Chiasson et al. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: Prevalence, risk factors and validity of Papanicolaou smears Obstet Gynaecol 84 1994 591-597
29. G. La ruche R. Ramon I. Mensah-Ado et al. Squamous intraepithelial lesions of the cervix, invasive cervical carcinoma and immunosuppression induced by human immunodeficiency virus in Africa Cancer 82 1998 2408-2410
30. M. Temmerman M.W. Tyndall N. Kidula et al. Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV-1 infection Int J Gynaecol Obstet 65 1999 171-181
31. H. Minkoff L. Ahdieh L.S. Massad et al. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women AIDS 15 2001 2157-2164
32. I. Heard J.M. Tassie M.D. Kazatchkine G. Orth Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women AIDS 16 2002 1799-1802
33. A.L. Moore C.A. Sabin S. Madge et al. Highly active antiretroviral therapy and cervical intraepithelial neoplasia AIDS 16 2002 927-929
34. E. Megevand L. Denny K. Dehaeck et al. Acetic acid visualisation of the cervix: An alternative to cytology screening Obstet Gynaecol 88 1996 383-386
35. University of Zimbabwe/JHPIEGO Cervical Cancer Project Visual inspection with acetic acid for cervical cancer screening: Test qualities in a primary care setting Lancet 353 1999 869-873
36. M. Maiman N. Tarricone J. Vieira et al. Colposcopic evaluation of human immunodeficiency virus seropositive women Obstet Gynaecol 78 1991 84-88
37. A. Goodman P.M. Chaudhuri N.J. Tobin-Enos M.L. Hutchinson The false negative rate of cervical smears in high risk HIV seropositive and seronegative women Int J Gynaecol Cancer 10 2000 27-32
38. The UK National Health Service Cancer Screening Programme (2004).
39. Z.M. Chirenje S. Rusakaniko V. Akino et al. Effect of HIV disease in treatment outcome of cervical squamous intraepithelial lesions among Zimbabwean women J Lower Gen Tract Dis 7 2003 16-21
40. M. Maiman D.H. Watts J. Andersen et al. Vaginal 5-fluorouracil for high grade cervical dysplasia in human immunodeficiency virus infection: A randomized trial Obstet Gynaecol 94 1999 954-961
41. K. Halcomb R.P. Mathews J.E. Chapman et al. The efficacy of cervical conization in the treatment of cervical intraepithelial neoplasia in HIV-positive women Gynaecol Oncol 74 3 1999 428-431
42. R.G. Frutcher M. Maiman A. Sedlis et al. Multiple recurrences of cervical intraepithelial neoplasia in women with human immunodeficiency virus Obstet Gynaecol 87 1996 338-344
43. M. Moodley J. Moodley I. Kleinschmidt Invasive cervical cancer and human immunodeficiency virus (HIV) infection: A South African perspective Int J Gynaecol Cancer 11 3 2001 194-197
44. R.G. Fruchter M. Maiman C.D. Arrastia et al. Is HIV infection a risk factor for advanced cervical cancer? J Acquir Immune Defic Syndr Hum Retrovirol 18 3 1998 241-245
45. P. Lomalisa T. Smith F. Guidozzi Human immunodeficiency virus infection and invasive cervical cancer in South Africa Gynaecol Oncol 77 3 2000 460-463
46. National Cancer Institute. Concurrent chemoradiation for cervical cancer. Clinical announcement, February 1999.
47. M. Dorruci B. Suligoi D. Sarraino et al. Incidence of invasive cervical cancer in a cohort of HIV-seropositive women before and after introduction of highly active antiretroviral therapy JAIDS 26 4 2001 377-380